We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
301
Protagonist Therapeutics
PTGX
$8.55B
$7.31M 0.04%
162,492
-111,326
-41% -$4.5M
TSCO icon
302
Tractor Supply
TSCO
$16.3B
$7.3M 0.04%
125,525
+1,345
+1% +$72.3K
KSPI icon
303
Kaspi.kz JSC
KSPI
$16.6B
$7.28M 0.04%
68,700
+3,500
+5% +$435K
BX icon
304
Blackstone
BX
$104B
$7.2M 0.04%
47,008
+4,768
+11% +$661K
OKTA icon
305
Okta
OKTA
$23.8B
$7.12M 0.04%
95,773
-52,733
-36% -$4.61M
STLD icon
306
Steel Dynamics
STLD
$36.4B
$7.12M 0.04%
56,465
-90,044
-61% -$10.9M
IBN icon
307
ICICI Bank
IBN
$107B
$7.04M 0.04%
236,000
-74,000
-24% -$2.15M
GTLS
308
DELISTED
Chart Industries
GTLS
$6.95M 0.04%
56,024
+14,406
+35% +$1.89M
NEO icon
309
NeoGenomics
NEO
$1.99B
$6.89M 0.04%
467,026
-20,000
-4% -$313K
WCC
310
WESCO International
WCC
$15.1B
$6.72M 0.04%
39,994
-1,768
-4% -$287K
CARR icon
311
Carrier Global
CARR
$49.8B
$6.69M 0.04%
83,099
+6,553
+9% +$456K
SCHW
312
Charles Schwab
SCHW
$182B
$6.64M 0.04%
102,446
+4,220
+4% +$277K
TREX icon
313
Trex
TREX
$4.4B
$6.53M 0.04%
98,027
+39,262
+67% +$2.76M
AKAM icon
314
Akamai
AKAM
$15.6B
$6.49M 0.04%
64,300
+1,724
+3% +$168K
PODD icon
315
Insulet
PODD
$11.8B
$6.3M 0.04%
27,061
+11,320
+72% +$2.32M
ETNB
316
DELISTED
89bio
ETNB
$6.28M 0.04%
848,079
– –
LRN icon
317
Stride
LRN
$4.16B
$6.27M 0.04%
73,534
+39,862
+118% +$3.08M
SNOW icon
318
Snowflake
SNOW
$98.1B
$6.25M 0.04%
54,457
+2,168
+4% +$267K
PTCT icon
319
PTC Therapeutics
PTCT
$6.18B
$6.24M 0.04%
+168,220
New +$5.63M
CBRE icon
320
CBRE Group
CBRE
$43.3B
$6.23M 0.04%
50,039
-2,948
-6% -$321K
JANX icon
321
Janux Therapeutics
JANX
$912M
$6.23M 0.04%
137,105
+25,101
+22% +$1.09M
USB icon
322
US Bancorp
USB
$97.9B
$6.17M 0.04%
134,940
-7,211
-5% -$316K
PRU icon
323
Prudential Financial
PRU
$42.6B
$6.14M 0.04%
50,743
+128
+0.3% +$15.1K
EXC icon
324
Exelon
EXC
$48.1B
$6.13M 0.04%
151,092
+10,532
+7% +$396K
CVS icon
325
CVS Health
CVS
$135B
$6.11M 0.04%
97,160
+755
+0.8% +$44K
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.